Tue, Dec 31, 11:04 AM (42 days ago)
This Form 10-Q/A amendment pertains to scPharmaceuticals Inc. (SCPH) for the quarter ending September 30, 2024. The amendment updates Item 5, adding disclosures regarding Rule 10b5-1 trading arrangements entered into by the CEO, John H. Tucker, and CFO, Rachael Nokes, for selling shares to cover tax obligations from vested restricted stock units (RSUs). The Tucker and Nokes Instruction Letters will remain effective as long as tax payments are required, but the number of shares to be sold is indeterminate. No changes to the financial statements are included in this amendment, and no new certifications under Section 906 of the Sarbanes-Oxley Act are provided. The amendment serves to clarify insider trading arrangements without altering existing financial disclosures. As of November 12, 2024, the company had 50,040,134 common shares outstanding, and it continues to operate as a smaller reporting company. The financial performance metrics and cash flow details remain unchanged from the original filing. Overall, this amendment focuses on compliance and transparency regarding insider trading rather than financial performance updates.